BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15587895)

  • 1. [Proteomics and its importance for gynecological oncology].
    Lacheta J; Cibula D; Freitag P; Zivný J
    Ceska Gynekol; 2004 Sep; 69(5):384-7. PubMed ID: 15587895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proteomics and biomarkers for detection of endometrial carcinoma].
    Kacerovský M; Tosner J
    Ceska Gynekol; 2009 Aug; 74(4):274-8. PubMed ID: 20564981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proteomics and biomarkers for detection of cervical cancer].
    Kacerovský M; Tosner J
    Ceska Gynekol; 2009 Oct; 74(5):335-8. PubMed ID: 20063836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current classification of malignant tumours in gynecological oncology--part I].
    Sehnal B; Driák D; Kmonícková E; Dvorská M; Hosová M; Citterbart K; Halaska M; Kolarík D
    Ceska Gynekol; 2011 Sep; 76(4):279-84. PubMed ID: 22026069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proteomics and biomarkers for detection of ovarian cancer].
    Kacerovský M; Tambor V; Lenco J; Tosner J
    Ceska Gynekol; 2009 Jun; 74(3):163-70. PubMed ID: 19642513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors of ovarian cancer].
    Jancárková N; Krkavcová M; Janashia M; Freitag P
    Ceska Gynekol; 2006 May; 71(3):252-9. PubMed ID: 16768055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current classification of malignant tumours in gynecological oncology--part II].
    Sehnal B; Driák D; Kmonícková E; Dvorská M; Hosová M; Citterbart K; Halaska M; Kolarík D
    Ceska Gynekol; 2011 Oct; 76(5):360-6. PubMed ID: 22132636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histopathologic prognostic factors, serum markers and selected molecular biologic factors in ovarian carcinoma].
    Spacek J; Jílek P; Petera J; Tesarík Z
    Ceska Gynekol; 2002 Nov; 67(6):343-9. PubMed ID: 12661373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ultrasound-guided minimally invasive interventions in gynecologic oncology].
    Zikán M; Fischerová D; Sláma J; Pinkavová I; Cibula D
    Ceska Gynekol; 2011 Sep; 76(4):257-61. PubMed ID: 22026065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proteomic applications in gynecology-obstetrics].
    De Seta F; Banco R; Guaschino S; De Santo D; Turrisi A; Piva C
    Minerva Ginecol; 2011 Feb; 63(1):39-46. PubMed ID: 21311419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant gynecologic neoplasms in the Czech Republic 1986-1995].
    Bouda J; Bouda J
    Ceska Gynekol; 2000 Jan; 65(1):58-63. PubMed ID: 10750302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ultrasound-guided minimally invasive interventions in gynecologic oncology].
    Zikán M
    Ceska Gynekol; 2014 Dec; 79(6):487-90. PubMed ID: 25585557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics of endometrial cancer diagnosis, treatment, and prognosis.
    Mittal P; Klingler-Hoffmann M; Arentz G; Zhang C; Kaur G; Oehler MK; Hoffmann P
    Proteomics Clin Appl; 2016 Mar; 10(3):217-29. PubMed ID: 26541900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic aspects of malignant epithelial ovarian tumours].
    Jancárková N; Krkavcová M; Janashia M; Freitag P
    Ceska Gynekol; 2005 Jul; 70(4):299-306. PubMed ID: 16128132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sexual morbidity after surgery for gynaecologic cancer].
    Velechovská P; Weiss P; Cibula D
    Ceska Gynekol; 2010 May; 75(3):171-6. PubMed ID: 20731295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk-reducing surgery in women at hereditary risk of gynaecological cancer].
    Zikán M
    Ceska Gynekol; 2011 Jun; 76(3):216-21. PubMed ID: 21838153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recommendation for genetic testing in patients suffering from gynecological malignancy].
    Zikán M
    Ceska Gynekol; 2015 Mar; 80(2):97-103. PubMed ID: 25944599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possibilities of increased radicality in pelvic exenteration].
    Cibula D; Freitag P; Fischerová D; Jancárková N; Sláma J; Zivný J
    Ceska Gynekol; 2005 Jan; 70(1):50-2. PubMed ID: 15779295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surface enhanced laser desorption/ionization (SELDI): proteomics technology and its application in oncology].
    Espejel F; Roa JC
    Med Clin (Barc); 2008 Sep; 131(8):312-7. PubMed ID: 18803927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of differential protein expression by brain metastases of gynecological malignancies.
    Yoshida A; Okamoto N; Tozawa-Ono A; Koizumi H; Kiguchi K; Ishizuka B; Kumai T; Suzuki N
    Hum Cell; 2013 Jun; 26(2):56-66. PubMed ID: 23504277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.